<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/css" href="/css/feed.css"?>
<rss xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
<channel>
<title>Poisoning and Drug Reference</title>
<link>//podcastplus.net/feed/podcast~2ad094ba12e3157fa407d8718ecd4fc4e2997dc82c884bca15a29c9176bd44ee</link>
<description>Podcastplus.net</description>
<pubDate>Sun, 18 Oct 2026 06:17:20 +0000</pubDate>
<item>
<title>Reducing the High Cost of Prescription Drugs in the U.S.</title>
<link>https://reachmd.com/programs/the-jama-report/reducing-high-cost-prescription-drugs-us/8333/podcast/16157.mp3?partner=itunes</link>
<description>    [Read the Article]     The increasing cost of prescription drugs in the United States has become a source of growing concern for patients, prescribers, payers, and policy makers. A new study examined the reasons for these high prices and also suggests policy changes that could help contain costs.   Researchers from Brigham and Women’s Hospital reviewed the medical and health policy literature on prescription drug prices in the U.S. and found high drug costs stem from various factors such as market exclusivity, limitations on payers and their ability to negotiate prices, and limitations on competition.   The researchers state that the most realistic short-term strategies include enforcing stricter requirements for exclusivity rights, ensuring timely generic drug availability, providing greater opportunities for price negotiation by patients, and effectively educating patients, prescribers, payers, and policy makers about these choices.     [Watch more videos of The JAMA Report]    </description>
<pubDate>Tue, 23 Aug 2016 04:00:00 +0000</pubDate>
<guid>https://reachmd.com/programs/the-jama-report/reducing-high-cost-prescription-drugs-us/8333/podcast/16157.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/the-jama-report/reducing-high-cost-prescription-drugs-us/8333/podcast/16157.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
<item>
<title>Increased Risk for Chronic Opioid Use After Surgery</title>
<link>https://reachmd.com/programs/the-jama-report/increased-risk-chronic-opioid-use-after-surgery/8236/podcast/16002.mp3?partner=itunes</link>
<description>    [Read the Article]     Chronic use of prescription pain medications known as opioids is increasing in the United States. New research shows that a portion of patients undergoing several common surgical procedures may be at increased risk for chronic opioid use several months after surgery.    Researchers from Stanford University School of Medicine reviewed the records of more than 641,000 patients who underwent one of 11 common operations and were not taking opioid pain medication during the year prior to surgery.   They found that some patients were at an increased risk for chronic opioid use following surgery, with the risks ranging from about one and a half times more likely, to as high as five times more likely, depending on the procedure. Males and the elderly had a higher risk, as well as patients with a history of drug or alcohol abuse. The overall risk of chronic opioid use remained low at about 1 percent depending on the type of surgery.     [Watch more videos of The JAMA Report]    </description>
<pubDate>Mon, 11 Jul 2016 04:00:00 +0000</pubDate>
<guid>https://reachmd.com/programs/the-jama-report/increased-risk-chronic-opioid-use-after-surgery/8236/podcast/16002.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/the-jama-report/increased-risk-chronic-opioid-use-after-surgery/8236/podcast/16002.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
<item>
<title>The Nation's Drug Czar Discusses Opioid Addiction Interventions</title>
<link>https://reachmd.com/programs/conversations-on-health-care/nations-drug-czar-discusses-opioid-addiction-interventions/8011/podcast/475.mp3?partner=itunes</link>
<description>   This week, hosts Mark Masselli and Margaret Flinter speak with Michael Botticelli, Director of the Office of National Drug Control Policy at the White House. The nation's "Drug Czar" talks about ONDCP's quest to battle the rising tide of opioid addiction and overdoses, now the leading cause of accidental death in America, by targeting resources towards more effective treatments and interventions.   </description>
<pubDate>Wed, 16 Mar 2016 04:00:00 +0000</pubDate>
<guid>https://reachmd.com/programs/conversations-on-health-care/nations-drug-czar-discusses-opioid-addiction-interventions/8011/podcast/475.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/conversations-on-health-care/nations-drug-czar-discusses-opioid-addiction-interventions/8011/podcast/475.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
<item>
<title>Water Warrior: The Scientist who Exposed the Contamination Crisis in Flint, Michigan</title>
<link>https://reachmd.com/programs/conversations-on-health-care/water-warrior-scientist-who-exposed-contamination-crisis-flint-michigan/7996/podcast/7640.mp3?partner=itunes</link>
<description>   This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Marc Edwards, MacArthur Foundation Fellow and Virginia Tech-based Civil Engineer who uncovered the Flint water crisis, where residents were poisoned from high levels of lead and other contaminants through the municipal drinking water. Dr. Edwards discusses his efforts to uncover the crisis, and his team's efforts to mitigate the water contamination crisis and related health issues.   </description>
<pubDate>Wed, 09 Mar 2016 05:00:00 +0000</pubDate>
<guid>https://reachmd.com/programs/conversations-on-health-care/water-warrior-scientist-who-exposed-contamination-crisis-flint-michigan/7996/podcast/7640.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/conversations-on-health-care/water-warrior-scientist-who-exposed-contamination-crisis-flint-michigan/7996/podcast/7640.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
<item>
<title>Increasing Use of Prescription Drugs in the U.S.</title>
<link>https://reachmd.com/programs/the-jama-report/increasing-use-prescription-drugs-us/7743/podcast/6551.mp3?partner=itunes</link>
<description>    [Read the Article]      Use of prescription drugs represents a major healthcare expense in the United States, and the number of adults taking prescription medications continues to increase. Researchers from the Harvard T.H. Chan School of Public Health examined trends in prescription drug use from 1999-2012 using data from nearly 40,000 adults, 20 years and older, who participated in the National Health and Nutrition Examination Survey. They found that the prevalence of prescription drug use increased from 51 percent in 1999-2000 to 59 percent in 2011-2012, while the use of five or more prescription drugs increased from 8 percent to 15 percent.     Eight of the 10 most commonly used drugs in 2011-2012 are used to treat components of the cardiometabolic syndrome, including high blood pressure, diabetes, and high cholesterol. Researchers note that the increase in use of several medications may reflect the growing need to treat obesity related complications. Use of antidepressants also increased from 7 perce...</description>
<pubDate>Mon, 09 Nov 2015 05:00:00 +0000</pubDate>
<guid>https://reachmd.com/programs/the-jama-report/increasing-use-prescription-drugs-us/7743/podcast/6551.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/the-jama-report/increasing-use-prescription-drugs-us/7743/podcast/6551.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
<item>
<title>A Look Back at Pharmacy Practice Over the Years</title>
<link>https://reachmd.com/programs/focus-on-pharmacy/a-look-back-at-pharmacy-practice-over-the-years/4092/podcast/13695.mp3?partner=itunes</link>
<description>Guest: Robert Rapp, PharmD  Host: Charles Turck, PharmD, BCPS, BCCCP   The practice of pharmacy has certainly changed over the years, with pharmacy schools and pharmacists making an effort to become more patient-centered. Still, sometimes it takes a retrospective look through the eyes of a healthcare professional who experienced those changes as they happened, to truly appreciate just how far the practice of pharmacy has come, and just how far its place in healthcare has truly evolved over the past few decades. Dr. Robert Rapp, professor of pharmacy and professor of surgery at the University of Kentucky, chronicles pharmacy practice of decades past and previews how he believes the dynamic between pharmacists and other healthcare professionals will continue to progress in the years to come. Dr. Charles Turck hosts.  </description>
<pubDate>Fri, 19 Dec 2008 18:00:50 +0000</pubDate>
<guid>https://reachmd.com/programs/focus-on-pharmacy/a-look-back-at-pharmacy-practice-over-the-years/4092/podcast/13695.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/focus-on-pharmacy/a-look-back-at-pharmacy-practice-over-the-years/4092/podcast/13695.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
<item>
<title>Efforts to Curb Disturbing Patterns in Internet Drug Sales</title>
<link>https://reachmd.com/programs/focus-on-pharmacy/efforts-to-curb-disturbing-patterns-in-internet-drug-sales/3431/podcast/10374.mp3?partner=itunes</link>
<description>Guest: Susan Foster, MSW  Host: Charles Turck, PharmD, BCPS, BCCCP   Up to 85 percent of all prescriptions purchased by patients on the Internet involve controlled substances, compared with just over 10 percent thru regular pharmacies. These figures, coming from independent, non-profit research, warn of serious problems of misuse by those who obtain drugs from the Web. What can be done-and what are we doing-to stop these sales? The National Center for Addiction and Substance Abuse (CASA) at Columbia University, has studied this issue extensively. Susan Foster, vice president and director of policy research and analysis at CASA, led the authoring of the Center's most recent report. She talks with host Dr. Charles Turck about what we can do to prevent unsupervised use of these medicines and better protect our patients from the associated dangers.  </description>
<pubDate>Wed, 30 Jul 2008 20:06:08 +0000</pubDate>
<guid>https://reachmd.com/programs/focus-on-pharmacy/efforts-to-curb-disturbing-patterns-in-internet-drug-sales/3431/podcast/10374.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/focus-on-pharmacy/efforts-to-curb-disturbing-patterns-in-internet-drug-sales/3431/podcast/10374.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
<item>
<title>Troubling Trends in Online Prescription Drug Sales</title>
<link>https://reachmd.com/programs/focus-on-pharmacy/troubling-trends-in-online-prescription-drug-sales/3430/podcast/10576.mp3?partner=itunes</link>
<description>Guest: Susan Foster, MSW  Host: Charles Turck, PharmD, BCPS, BCCCP   We're learning more about the hundreds of Internet sites that advertise or sell controlled medications by mail. Yet a new set of answers brings a series of worrisome questions: How many of these websites actually require a prescription for controlled substances? Do many of those who buy prescription drugs online do so with nefarious intentions? Dr. Charles Turck probes problematic developments in online drug sales with Susan Foster, vice president and director of policy research and analysis at the National Center on Addiction and Substance Abuse at Columbia University. Ms. Foster directed the preparation of the Center's most recent  You've Got Drugs  report on spurious drug sales on the Internet.  </description>
<pubDate>Wed, 30 Jul 2008 20:05:46 +0000</pubDate>
<guid>https://reachmd.com/programs/focus-on-pharmacy/troubling-trends-in-online-prescription-drug-sales/3430/podcast/10576.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/focus-on-pharmacy/troubling-trends-in-online-prescription-drug-sales/3430/podcast/10576.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
<item>
<title>Biogeneric Drugs</title>
<link>https://reachmd.com/programs/washington-health-report/biogeneric-drugs/1801/podcast/7076.mp3?partner=itunes</link>
<description>Guest: Marilyn Werber-Serafini  Host: Paul Raeburn   Biogenerics are generic versions of biotech drugs made from cells and other living organisms. They could save consumers and the health care system a lot of money. Here to tell us about them is a reporter who has been covering health care for National Journal for more than a decade. She written extensively about Medicare, the uninsured, and physicians.  </description>
<pubDate>Tue, 16 Oct 2007 19:54:21 +0000</pubDate>
<guid>https://reachmd.com/programs/washington-health-report/biogeneric-drugs/1801/podcast/7076.mp3?partner=itunes</guid>
<enclosure url="https://reachmd.com/programs/washington-health-report/biogeneric-drugs/1801/podcast/7076.mp3?partner=itunes" type="audio/mpeg" length="1"/>
</item>
</channel>
</rss>
